Literature DB >> 15490262

Human parathyroid hormone (1-34) increases mass and structure of the cortical shell, with resultant increase in lumbar bone strength, in ovariectomized rats.

Shinobu Arita1, Satoshi Ikeda, Akinori Sakai, Nobukazu Okimoto, Shojiro Akahoshi, Masato Nagashima, Akifumi Nishida, Masako Ito, Toshitaka Nakamura.   

Abstract

Estrogen deficiency causes reduction of bone mass and abnormal bone microarchitecture, consequently reducing bone strength. Human parathyroid hormone (hPTH) (1-34) increases bone mass and strength. To clarify the factors that determine the recovery of bone strength in the lumbar vertebrae of ovariectomized rats by intermittent hPTH administration, we analyzed the relationship between skeletal measurements and bone strength. Human PTH (1-34) administration resulted in recovery of cortical bone mineral content (BMC) and cortical bone area to sham the levels, but in resulted in a less pronounced recovery of trabecular BMC and no increase in the total cross-sectional area of the vertebral body. Of the three-dimensional (3D) trabecular bone parameters, hPTH (1-34) increased trabecular thickness (Tb.Th). The cortical shell area of L4, determined by histomorphometry, was also increased. In hPTH-treated rats, the only determinant of the compressive load of L5 was the cortical shell BMC, in the early recovery period (days 42-84). Our data suggest that increased cortical bone mass contributes more than trabecular bone mass and structure to the recovery of bone strength in response to hPTH therapy in the rat lumbar vertebral body after ovariectomy. Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15490262     DOI: 10.1007/s00774-004-0520-4

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  13 in total

1.  Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study.

Authors:  C Senn; B Günther; A W Popp; R Perrelet; D Hans; K Lippuner
Journal:  Osteoporos Int       Date:  2014-04-24       Impact factor: 4.507

2.  Recent progress in bone imaging for osteoporosis research.

Authors:  Masako Ito
Journal:  J Bone Miner Metab       Date:  2011-02-08       Impact factor: 2.626

3.  Characteristics of bone turnover, bone mass and bone strength in Spontaneously Diabetic Torii-Lepr fa rats.

Authors:  Shuichi Kimura; Tomohiko Sasase; Takeshi Ohta; Eimei Sato; Mutsuyoshi Matsushita
Journal:  J Bone Miner Metab       Date:  2011-10-27       Impact factor: 2.626

4.  Ligand-mediated activation of an engineered gs g protein-coupled receptor in osteoblasts increases trabecular bone formation.

Authors:  Edward C Hsiao; Susan M Millard; Alyssa Louie; Yong Huang; Bruce R Conklin; Robert A Nissenson
Journal:  Mol Endocrinol       Date:  2010-02-11

Review 5.  Increasing dietary phosphorus intake from food additives: potential for negative impact on bone health.

Authors:  Eiji Takeda; Hironori Yamamoto; Hisami Yamanaka-Okumura; Yutaka Taketani
Journal:  Adv Nutr       Date:  2014-01-01       Impact factor: 8.701

6.  Effect of sequential treatments with alendronate, parathyroid hormone (1-34) and raloxifene on cortical bone mass and strength in ovariectomized rats.

Authors:  Sarah K Amugongo; Wei Yao; Junjing Jia; Weiwei Dai; Yu-An E Lay; Li Jiang; Danielle Harvey; Elizabeth A Zimmermann; Eric Schaible; Neil Dave; Robert O Ritchie; Donald B Kimmel; Nancy E Lane
Journal:  Bone       Date:  2014-07-10       Impact factor: 4.398

7.  Modifications in bone matrix of estrogen-deficient rats treated with intermittent PTH.

Authors:  Rafael Pacheco-Costa; Jenifer Freitas Campos; Eduardo Katchburian; Valquíria Pereira de Medeiros; Helena Bonciani Nader; Keico Okino Nonaka; Lilian Irene Plotkin; Rejane Daniele Reginato
Journal:  Biomed Res Int       Date:  2015-01-28       Impact factor: 3.411

8.  Effect of osteoporosis treatment agents on the cortical bone osteocyte microenvironment in adult estrogen-deficient, osteopenic rats.

Authors:  Amber Rath Stern; Xiaomei Yao; Yong Wang; Amanuel Berhe; Mark Dallas; Mark L Johnson; Wei Yao; Donald B Kimmel; Nancy E Lane
Journal:  Bone Rep       Date:  2018-02-26

9.  A Novel Peptide, CK2.3, Improved Bone Formation in Ovariectomized Sprague Dawley Rats.

Authors:  Linda Sequeira; John Nguyen; Liyun Wang; Anja Nohe
Journal:  Int J Mol Sci       Date:  2020-07-10       Impact factor: 5.923

10.  Differences in the effects of BMI on bone microstructure between loaded and unloaded bones assessed by HR-pQCT in Japanese postmenopausal women.

Authors:  Norifumi Fujii; Manabu Tsukamoto; Nobukazu Okimoto; Miyuki Mori; Yoshiaki Ikejiri; Toru Yoshioka; Makoto Kawasaki; Nobuhiro Kito; Junya Ozawa; Ryoichi Nakamura; Shogo Takano; Saeko Fujiwara
Journal:  Osteoporos Sarcopenia       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.